Ga Eun Park

Dr. Ga Eun Park


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2019 in Medical Ultrasonography
Verified
Journal Article
Closed access
JLJeongmin Lee
Jeongmin Lee
SKSanghee Kim
Sanghee Kim
BKBong Joo Kang
Bong Joo Kang
SKSung Hun Kim
Sung Hun Kim
GPGa Eun Park
Ga Eun Park
Aim: To investigate the effect of a computer-aided diagnosis (CAD) system on breast ultrasound (US) for inexperienced radiologists in describing and determining breast lesions.Materials and methods: Between October 2015 to January 2017, 500 suspicious or probable benign lesions in 413 patients were reviewed. Five experienced readers retrospectively reviewed for each of 100 lesions according to the Breast Imaging Reporting and Data System (BI-RADS) lexicon and category, with CAD system (S-detectTM). The readers then made final decisions by combining CAD results to their US results. Using the nested experiment design, five inexperienced readers were asked to select the appropriate BI-RADS lexicons, categories, CAD results, and combination results for each of the 100 lesions, retrospectively. Diagnostic performance of experienced and inexperienced radiologists and CAD were assessed. For each case, agreements in the lexicons and categories were analyzed among the experienced reader, inexperienced reader and CAD.Results: Indicators of the diagnostic performance for breast malignancy of the experienced group (AUC=0.83, 95%CI [0.80, 0.86]) were similar or higher than those of CAD (AUC = 0.79, 95%CI[0.74, 0.83], p=0.101), except for specificity. Conversely, indicators of diagnostic performance of inexperienced group (AUC=0.65, 95%CI[0.58, 0.71]) did not differ from or were lower than those of CAD(AUC=0.73, 95%CI[0.67, 0.78], p=0.013). Also, the diagnostic performance of the inexperienced group after combination with the CAD result was significantly improved (0.71, 95% CI [0.65, 0.77], p=0.001), whereas that of the experienced group did not change after combination with the CAD result, except for specificity and positive predictive value (PPV). Kappa values for the agreement of the categorization between CAD and each radiologist group were increased after applying the CAD result to their result of general US. Especially, the increase of the Kappa value was higher in the inexperienced group than in the experienced group. Also, for all the lexicons, the Kappa values between the experienced group and CAD were higher than those between the inexperienced group and CAD.Conclusion: By using the CAD system for classification of breast lesions, diagnostic performance of the inexperienced radiologists for malignancy was significantly improved, and better agreement was observed in lexicons between the experienced group and CAD than between the inexperienced group and CAD. CAD may be beneficial and educational for the inexperienced group.

2 February 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
GPGa Eun Park
Ga Eun Park
BKBong Joo Kang
Bong Joo Kang
SKSung Hun Kim
Sung Hun Kim
JLJeongmin Lee
Jeongmin Lee
To investigate whether artificial-intelligence-based, computer-aided diagnosis (AI-CAD) could facilitate the detection of missed cancer on digital mammography, a total of 204 women diagnosed with breast cancer with diagnostic (present) and prior mammograms between 2018 and 2020 were included in this study. Two breast radiologists reviewed the mammographic features and classified them into true negative, minimal sign or missed cancer. They analyzed the AI-CAD results with an abnormality score and assessed whether the AI-CAD correctly localized the known cancer sites. Of the 204 cases, 137 were classified as true negative, 33 as minimal signs, and 34 as missed cancer. The sensitivity, specificity and diagnostic accuracy of AI-CAD were 84.7%, 91.5% and 86.3% on diagnostic mammogram and 67.2%, 91.2% and 83.38% on prior mammogram, respectively. The AI-CAD correctly localized 27 cases from 34 missed cancers on prior mammograms. The findings in the preceding mammography of AI-CAD-detected missed cancer were common in the order of calcifications, focal asymmetry and asymmetry. Asymmetry was the most common finding among the seven cases, which could not be detected by AI-CAD in the missed cases (5/7). The assistance of AI-CAD can be helpful in the early detection of breast cancer in mammography screenings.

11 September 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
JLJeongmin Lee
Jeongmin Lee
BKBong Joo Kang
Bong Joo Kang
GPGa Eun Park
Ga Eun Park
SKSung Hun Kim
Sung Hun Kim
The purpose of this study is to investigate the usefulness of magnetic resonance imaging (MRI) for the detection of local recurrence after nipple-sparing mastectomy (NSM) or skin-sparing mastectomy (SSM) with immediate reconstructive surgery for breast cancer. Two hundred and eighty-six NSM or SSM procedures and immediate reconstruction cases between August 2015 and February 2020 were reviewed. The detectability rates of for local recurrence using MRI and ultrasound were assessed, and the characteristics of recurrent and primary cancers were evaluated. The patients with multifocal or multicentric primary cancer and a dense parenchymal pattern showed a higher recurrence rate (p < 0.001). A total of 22 cases showed recurrence, and due to multifocal recurrence, a total of 27 recurrent lesions were identified in the reconstructed breast, of which 12 were symptomatic and 15 were asymptomatic (p < 0.001). With the exception of skin recurrence (n = 6), MRI showed a significantly higher detectability rate (95.2%, 20 of 21) than ultrasound (38.1%, 8 of 21) for the recurrence of cancer in the reconstructed breast (p < 0.001), especially for small-sized (<1 cm) asymptomatic lesions. In addition, the mean recurrence interval of MRI-detected asymptomatic lesions was 21.7 months (SD ± 17.7), which was significantly longer than that of symptomatic recurrence. In conclusion, postoperative MRI can be useful for identifying small-sized (<1 cm) asymptomatic recurrence lesions in reconstructed breast tissue after NSM or SSM, which can be implemented within two years of surgery.

24 February 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
JLJeongmin Lee
Jeongmin Lee
BKBong Joo Kang
Bong Joo Kang
SKSung Hun Kim
Sung Hun Kim
GPGa Eun Park
Ga Eun Park
The present study evaluated the effectiveness of computer-aided detection (CAD) system in screening automated breast ultrasound (ABUS) and analyzed the characteristics of CAD marks and the causes of false-positive marks. A total of 846 women who underwent ABUS for screening from January 2017 to December 2017 were included. Commercial CAD was used in all ABUS examinations, and its diagnostic performance and efficacy in shortening the reading time (RT) were evaluated. In addition, we analyzed the characteristics of CAD marks and the causes of false-positive marks. A total of 1032 CAD marks were displayed based on the patient and 534 CAD marks on the lesion. Five cases of breast cancer were diagnosed. The sensitivity, specificity, PPV, and NPV of CAD were 60.0%, 59.0%, 0.9%, and 99.6% for 846 patients. In the case of a negative study, it was less time-consuming and easier to make a decision. Among 530 false-positive marks, 459 were identified clearly for pseudo-lesions; the most common cause was marginal shadowing, followed by Cooper’s ligament shadowing, peri-areolar shadowing, rib, and skin lesions. Even though CAD does not improve the performance of ABUS and a large number of false-positive marks were detected, the addition of CAD reduces RT, especially in the case of negative screening ultrasound.

14 September 2022 in Cancers
Verified
Journal Article
Open access
PDF file
JLJeongmin Lee
Jeongmin Lee
SKSung Hun Kim
Sung Hun Kim
YKYelin Kim
Yelin Kim
JPJAEWOO PARK
JAEWOO PARK
GPGa Eun Park
Ga Eun Park
BKBong Joo Kang
Bong Joo Kang
This study aimed to predict early breast cancer recurrence in women under 40 years of age using radiomics signature and clinicopathological information. We retrospectively investigated 155 patients under 40 years of age with invasive breast cancer who underwent MRI and surgery. Through stratified random sampling, 111 patients were assigned as the training set, and 44 were assigned as the validation set. Recurrence-associated factors were investigated based on recurrence within 5 years during the total follow-up period. A Rad-score was generated through texture analysis (3D slicer, ver. 4.8.0) of breast MRI using the least absolute shrinkage and selection operator Cox regression model. The Rad-score showed a significant association with disease-free survival (DFS) in the training set (p = 0.003) and validation set (p = 0.020) in the Kaplan–Meier analysis. The nomogram was generated through Cox proportional hazards models, and its predictive ability was validated. The nomogram included the Rad-score and estrogen receptor negativity as predictive factors and showed fair DFS predictive ability in both the training and validation sets (C-index 0.63, 95% CI 0.45–0.79). In conclusion, the Rad-score can predict the disease recurrence of invasive breast cancer in women under 40 years of age, and the Rad-score-based nomogram showed reasonably high DFS predictive ability, especially within 2 years of surgery.

24 October 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
DSDonghun Song
Donghun Song
BKBong Joo Kang
Bong Joo Kang
SKSung Hun Kim
Sung Hun Kim
JLJeongmin Lee
Jeongmin Lee
GPGa Eun Park
Ga Eun Park
Breast MR is the most sensitive imaging modality, but there are cases of malignant tumors that are not detected in MR. This study evaluated the frequency and main causes of malignant breast lesions not detected in dynamic contrast-enhanced (DCE) MR. A total of 1707 cases of preoperative breast MR performed between 2020 and 2021 were included. Three radiologists individually reviewed the DCE MRs and found not-detected malignancy cases in the MRs. The final cases were decided through consensus. For the selected cases, images other than DCE MRIs, such as mammography, ultrasounds, diffusion-weighted MRs, and, if possible, contrast-enhanced chest CTs, were analyzed. In the final sample, 12 cases were not detected in DCE MR, and the frequency was 0.7% (12/1707). Six cases were not detected due to known non-enhancing histologic features. In four cases, tumors were located in the breast periphery and showed no enhancement in MR. In the remaining two cases, malignant lesions were not identified due to underlying marked levels of BPE. The frequency of not-detected malignancy in DCE MR is rare. Knowing the causes of each case and correlating it with other imaging modalities could be helpful in the diagnosis of breast malignancy in DCE MR.